Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8671 |
High Similarity |
NPD6190 |
Approved |
0.8507 |
High Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.8301 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8299 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.8235 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8219 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.8214 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.8182 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8169 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.8156 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.8156 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.8143 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.8138 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.8013 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7987 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7985 |
Intermediate Similarity |
NPD5536 |
Phase 2 |
0.7972 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7962 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7937 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7937 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.7933 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7927 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7892 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7887 |
Intermediate Similarity |
NPD7095 |
Approved |
0.7852 |
Intermediate Similarity |
NPD4109 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD4110 |
Phase 3 |
0.7821 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.7821 |
Intermediate Similarity |
NPD2801 |
Approved |
0.7805 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7805 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7803 |
Intermediate Similarity |
NPD228 |
Approved |
0.7793 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7792 |
Intermediate Similarity |
NPD3455 |
Phase 2 |
0.7778 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7778 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7764 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7758 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7756 |
Intermediate Similarity |
NPD37 |
Approved |
0.7756 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7733 |
Intermediate Similarity |
NPD8166 |
Discontinued |
0.773 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7727 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7722 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7722 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7722 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7718 |
Intermediate Similarity |
NPD4534 |
Discontinued |
0.7712 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7708 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7703 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7692 |
Intermediate Similarity |
NPD6386 |
Approved |
0.7692 |
Intermediate Similarity |
NPD6385 |
Approved |
0.7683 |
Intermediate Similarity |
NPD7054 |
Approved |
0.7667 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7664 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7647 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7647 |
Intermediate Similarity |
NPD3146 |
Approved |
0.7647 |
Intermediate Similarity |
NPD3688 |
Clinical (unspecified phase) |
0.7643 |
Intermediate Similarity |
NPD1608 |
Approved |
0.764 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7636 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7636 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7628 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7603 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7603 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD5958 |
Discontinued |
0.7595 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7593 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7582 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7576 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7556 |
Intermediate Similarity |
NPD5283 |
Phase 1 |
0.7551 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7544 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7536 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.7531 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7516 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD1358 |
Approved |
0.7467 |
Intermediate Similarity |
NPD1501 |
Clinical (unspecified phase) |
0.7467 |
Intermediate Similarity |
NPD2438 |
Suspended |
0.7466 |
Intermediate Similarity |
NPD3764 |
Approved |
0.7455 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7451 |
Intermediate Similarity |
NPD2354 |
Approved |
0.7451 |
Intermediate Similarity |
NPD3887 |
Approved |
0.7448 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.744 |
Intermediate Similarity |
NPD7038 |
Approved |
0.744 |
Intermediate Similarity |
NPD7039 |
Approved |
0.7429 |
Intermediate Similarity |
NPD17 |
Approved |
0.7417 |
Intermediate Similarity |
NPD5763 |
Approved |
0.7417 |
Intermediate Similarity |
NPD5762 |
Approved |
0.7413 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7407 |
Intermediate Similarity |
NPD919 |
Approved |
0.7394 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.7386 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7379 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7376 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.7375 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7368 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7365 |
Intermediate Similarity |
NPD1558 |
Phase 1 |
0.7361 |
Intermediate Similarity |
NPD2797 |
Approved |
0.7355 |
Intermediate Similarity |
NPD4357 |
Discontinued |
0.7351 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7346 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.7343 |
Intermediate Similarity |
NPD2982 |
Phase 2 |
0.7343 |
Intermediate Similarity |
NPD2983 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7324 |
Intermediate Similarity |
NPD3705 |
Approved |
0.7315 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3536 |
Discontinued |
0.7308 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD1778 |
Approved |
0.7299 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.7293 |
Intermediate Similarity |
NPD3134 |
Approved |
0.7285 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7285 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7285 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7278 |
Intermediate Similarity |
NPD3687 |
Approved |
0.7278 |
Intermediate Similarity |
NPD3686 |
Approved |
0.7273 |
Intermediate Similarity |
NPD2981 |
Phase 2 |
0.7273 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7267 |
Intermediate Similarity |
NPD6653 |
Approved |
0.7262 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7261 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7261 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.726 |
Intermediate Similarity |
NPD3018 |
Phase 2 |
0.7259 |
Intermediate Similarity |
NPD3021 |
Approved |
0.7259 |
Intermediate Similarity |
NPD3022 |
Approved |
0.7255 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7254 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.725 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7248 |
Intermediate Similarity |
NPD826 |
Approved |
0.7248 |
Intermediate Similarity |
NPD3619 |
Clinical (unspecified phase) |
0.7248 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7248 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.7248 |
Intermediate Similarity |
NPD3620 |
Phase 2 |
0.7248 |
Intermediate Similarity |
NPD825 |
Approved |
0.7241 |
Intermediate Similarity |
NPD1203 |
Approved |
0.7235 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7234 |
Intermediate Similarity |
NPD1357 |
Approved |
0.7234 |
Intermediate Similarity |
NPD5585 |
Approved |
0.723 |
Intermediate Similarity |
NPD3268 |
Approved |
0.7229 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7222 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7208 |
Intermediate Similarity |
NPD3060 |
Approved |
0.7203 |
Intermediate Similarity |
NPD422 |
Phase 1 |
0.7203 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7202 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7192 |
Intermediate Similarity |
NPD5647 |
Approved |
0.719 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD2353 |
Approved |
0.719 |
Intermediate Similarity |
NPD2355 |
Clinical (unspecified phase) |
0.719 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7188 |
Intermediate Similarity |
NPD4972 |
Discontinued |
0.7183 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7178 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7172 |
Intermediate Similarity |
NPD3225 |
Approved |
0.7161 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.716 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.716 |
Intermediate Similarity |
NPD1006 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7153 |
Intermediate Similarity |
NPD9269 |
Phase 2 |
0.7152 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7152 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7143 |
Intermediate Similarity |
NPD6873 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7135 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7133 |
Intermediate Similarity |
NPD943 |
Approved |
0.7126 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7125 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7125 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7124 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7124 |
Intermediate Similarity |
NPD6032 |
Approved |
0.7122 |
Intermediate Similarity |
NPD690 |
Clinical (unspecified phase) |
0.7122 |
Intermediate Similarity |
NPD2629 |
Approved |
0.7113 |
Intermediate Similarity |
NPD1651 |
Approved |
0.7113 |
Intermediate Similarity |
NPD5691 |
Approved |
0.711 |
Intermediate Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.7108 |
Intermediate Similarity |
NPD2821 |
Approved |
0.7105 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7101 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7101 |
Intermediate Similarity |
NPD2163 |
Approved |
0.7101 |
Intermediate Similarity |
NPD7843 |
Approved |
0.7097 |
Intermediate Similarity |
NPD4236 |
Phase 3 |
0.7097 |
Intermediate Similarity |
NPD4237 |
Approved |
0.7095 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7086 |
Intermediate Similarity |
NPD555 |
Phase 2 |
0.7086 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7081 |
Intermediate Similarity |
NPD7028 |
Phase 2 |
0.7071 |
Intermediate Similarity |
NPD7157 |
Approved |
0.707 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7066 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7059
|
Intermediate Similarity |
NPD3748 |
Approved |